CAREERS · LINKEDIN JOB POSTING
Founding Commercial Partner gfCas12a (CRISPR) Licensing · Remote, US-based · Equity + Uncapped Revenue Share
G+FLAS Life Sciences, Inc. — a Seoul National University spin-out and owner of the proprietary gfCas12a (mgCas12a) genome-editing platform — is opening a principal-level commercial seat to drive the global out-licensing and partnering of our CRISPR technology across cell & gene therapy, diagnostics and bioproduction.
The upsideThis is a principal's seat. You earn equity in the company and an uncapped share of the licensing revenue you generate — we only win when you win. Business expenses are covered at cost.
What you'll be selling — and why it closesYou won't be pushing a science project. You'll be licensing a de-risked, defensible platform:
● Our own CRISPR nuclease — granted patents in the US, Korea & Japan; a genuine freedom-to-operate advantage over the incumbent Cas9/Cas12a estates.
● Differentiated technology: exonuclease-fused editing for deeper knockout, and a one-pot, 30-minute point-of-care Detector (e.g., antibiotic-resistance screening).
● A Seoul National University spin-out already partnered with Bayer, Kolon and Kolmar — credibility that opens doors.
How you'll work● Run your own book. Fully remote, independent — no office, no timesheets, no micromanagement.
● Direct line to the founder-CEO (an SNU professor): decisions in days, not quarters.
● Own the pipeline end-to-end: outreach → technical pitch → term sheets → close; represent us at J.P. Morgan, BIO, ASGCT, Advanced Therapies and beyond.
Who thrives here● A proven closer in cell & gene therapy licensing/BD — ideally with CRISPR / genome-editing deals signed.
● Demonstrated deal-making and fundraising — you have sourced and closed partnerships and licenses.
● Strong network across pharma/biotech, platform companies and investors; US-based, operating globally.
● Entrepreneurial and performance-driven, equity-minded — you'd rather own your upside than draw a fixed base.
Make your caseWe're hiring one person — and we select on your plan, not your résumé. To be considered:
● Review our gfCas12a Technology & Licensing Brief (attached).
● Send your CV plus a concise BD Plan — how you would turn gfCas12a into revenue (strategy, target segments/accounts, first moves).
● If your plan is sharp, we'll talk. Shortlisted candidates are invited to interview.
Apply to: choe@gflas.com Learn more: https://gflas.com
G+FLAS Life Sciences is an equal-opportunity organization. This is a contract (independent contractor) engagement.
#CRISPR #GeneTherapy #CellTherapy #BusinessDevelopment #Licensing #Biotech #gfCas12a #RemoteJobs